Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

TXA (Tranexamic Acid) vs. Amicar (Aminocaproic Acid) in Total Knee and Hip Arthroplasty- Effectiveness, Safety, and Cost Analysis

NCT02030821 is registered in ClinicalTrials.gov with Duke University as lead sponsor.

NCT NCT02030821
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02030821 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
TXA (Tranexamic Acid) vs. Amicar (Aminocaproic Acid) in Total Knee and Hip Arthroplasty- Effectiveness, Safety, and Cost Analysis
Lead sponsor
Duke University
Phase
Phase 4
Overall status
Completed
Start date
January 31, 2015
Completion date
November 12, 2017
Enrollment
246 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

blood loss, hip arthritis, knee arthritis